# Patients Undergoing Continuous Venovenous Hemodiafiltration: Effects of Increased Blood Flow

> **NCT05796661** · NA · UNKNOWN · sponsor: **Hospital Israelita Albert Einstein** · enrollment: 27 (actual)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **OTHER:** Effects of increased blood flow during regional anticoagulation with 4% trisodium citrate in patients undergoing continuous venovenous hemodiafiltration

## Key facts

- **NCT ID:** NCT05796661
- **Lead sponsor:** Hospital Israelita Albert Einstein
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-09
- **Primary completion:** 2023-01-09
- **Final completion:** 2024-09-30
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2024-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05796661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05796661, "Patients Undergoing Continuous Venovenous Hemodiafiltration: Effects of Increased Blood Flow". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05796661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*